Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-01 Sale | 2023-06-02 5:01 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 6,500 | $4.4537 | $28,949 | 783,066 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 5:01 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 6,800 | $4.424 | $30,083 | 789,566 (Direct) | View |
| 2023-04-03 Sale | 2023-04-04 5:03 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 6,700 | $3.691 | $24,730 | 796,366 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 5:04 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 7,000 | $3.4243 | $23,970 | 806,681 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 5:08 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 7,700 | $3.7923 | $29,201 | 928,681 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 7:30 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 6,970 | $3.1759 | $22,136 | 751,913 (Direct) | View |
| 2022-12-01 Sale | 2022-12-05 4:35 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 9,400 | $3.9089 | $36,744 | 761,151 (Direct) | View |
| 2022-10-03 Sale(A) | 2022-11-23 5:01 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 9,500 | $3.9061 | $37,108 | 1,570,002 (Direct) | View |
| 2022-11-01 Sale | 2022-11-03 4:49 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 9,700 | $4.0263 | $39,055 | 765,059 (Direct) | View |
| 2022-09-30 Sale | 2022-10-04 4:59 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 14,992 | $3.9415 | $59,091 | 774,759 (Direct) | View |
| 2022-09-01 Sale | 2022-09-02 5:00 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 10,423 | $4.4121 | $45,987 | 789,751 (Direct) | View |
| 2022-08-01 Sale | 2022-08-03 6:00 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 10,423 | $4.4522 | $46,405 | 800,174 (Direct) | View |
| 2022-07-18 Sale | 2022-07-20 6:00 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 20,000 | $4.8656 | $97,312 | 810,597 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 6:16 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 9,100 | $5.0326 | $45,797 | 830,597 (Direct) | View |
| 2022-06-17 Sale | 2022-06-21 7:23 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 9,200 | $4.6778 | $43,036 | 739,697 (Direct) | View |
| 2022-05-17 Sale | 2022-05-19 6:01 pm | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 85,000 | $5.1733 | $439,734 | 748,897 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-31 Tax Withholding | 2023-04-04 5:03 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 3,615 | $3.9 | 796,366 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:08 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 192,200 | $0 | 928,681 (Direct) | View |
| 2022-09-30 Tax Withholding | 2023-01-13 5:40 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 7,732 | $4.25 | 782,019 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 7:30 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 2,268 | $3.1 | 751,913 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 6:16 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE EVP & Chairman of Development | 100,000 | $0 | 830,597 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 6:30 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-06-01 8:48 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | YVER ANTOINE Chief Medical Officer | 833,897 | $0 | 833,897 (Direct) | View |